Clinical Trial Update: Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial updating second-line chemotherapy FOLFIRINOX in unresectable cholangiocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• FOLFIRINOX

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Cholangiocarcinoma | Phase 2 | Status: COMPLETED